{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:18:49Z","timestamp":1777382329171,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["grant no.: SB\/YS\/LS-321\/2013"],"award-info":[{"award-number":["grant no.: SB\/YS\/LS-321\/2013"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR10484\/MED\/29\/281\/2013"],"award-info":[{"award-number":["BT\/PR10484\/MED\/29\/281\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00203-021-02474-5","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T17:03:27Z","timestamp":1625850207000},"page":"4891-4899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-mycobacterial activity evaluation of designed peptides: cryptic and database filtering based approach"],"prefix":"10.1007","volume":"203","author":[{"given":"Sneha","family":"Raj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umamageswaran","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra","family":"Kalyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesu","family":"Arockiaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju Y.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-6257","authenticated-orcid":false,"given":"Mukesh","family":"Pasupuleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"2474_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/jac\/dku570%JJournalofAntimicrobialChemotherapy","volume":"70","author":"M Abedinzadeh","year":"2015","unstructured":"Abedinzadeh M, Gaeini M, Sardari S (2015) Natural antimicrobial peptides against Mycobacterium tuberculosis. J Antimicrob Chemother 70:1285\u20131289. https:\/\/doi.org\/10.1093\/jac\/dku570%JJournalofAntimicrobialChemotherapy","journal-title":"J Antimicrob Chemother"},{"key":"2474_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3201\/eid1608.100314","volume":"16","author":"KA Alexander","year":"2010","unstructured":"Alexander KA, Laver PN, Michel AL, Williams M, van Helden PD, Warren RM, Gey van Pittius NC (2010) Novel Mycobacterium tuberculosis complex pathogen M. mungi. Emerg Infect Dis 16:1296\u20131299","journal-title":"Emerg Infect Dis"},{"key":"2474_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.phrs.2017.10.011","volume":"128","author":"M AlMatar","year":"2018","unstructured":"AlMatar M, Makky EA, Yakici G, Var I, Kayar B, Koksal F (2018) Antimicrobial peptides as an alternative to anti-tuberculosis drugs. Pharmacol Res 128:288\u2013305. https:\/\/doi.org\/10.1016\/j.phrs.2017.10.011","journal-title":"Pharmacol Res"},{"key":"2474_CR4","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1073\/pnas.0700036104","volume":"104","author":"S Alonso","year":"2007","unstructured":"Alonso S, Pethe K, Russell DG, Purdy GE (2007) Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci USA 104:6031\u20136036. https:\/\/doi.org\/10.1073\/pnas.0700036104","journal-title":"Proc Natl Acad Sci USA"},{"key":"2474_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00018-016-2422-8","volume":"74","author":"JA Awuh","year":"2017","unstructured":"Awuh JA, Flo TH (2017) Molecular basis of mycobacterial survival in macrophages. Cell Mol Life SciS 74:1625\u20131648. https:\/\/doi.org\/10.1007\/s00018-016-2422-8","journal-title":"Cell Mol Life SciS"},{"key":"2474_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/092986611794328627","volume":"18","author":"C Barthe","year":"2011","unstructured":"Barthe C, Hocquellet A, Garbay B (2011) Bacteriostatic activity of the proregion of human hepcidin. Protein Pept Lett 18:36\u201340. https:\/\/doi.org\/10.2174\/092986611794328627","journal-title":"Protein Pept Lett"},{"key":"2474_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LCK Bell","year":"2018","unstructured":"Bell LCK, Noursadeghi M (2018) Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol 16:80\u201390. https:\/\/doi.org\/10.1038\/nrmicro.2017.128","journal-title":"Nat Rev Microbiol"},{"key":"2474_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/femsre\/fuz006","volume":"43","author":"C Bussi","year":"2019","unstructured":"Bussi C, Gutierrez MG (2019) Mycobacterium tuberculosis infection of host cells in space and time. FEMS Microbiol Rev 43:341\u2013361. https:\/\/doi.org\/10.1093\/femsre\/fuz006","journal-title":"FEMS Microbiol Rev"},{"key":"2474_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00060-17","author":"S Cano-Muniz","year":"2018","unstructured":"Cano-Muniz S, Anthony R, Niemann S, Alffenaar JC (2018) New approaches and therapeutic options for Mycobacterium tuberculosis in a dormant state. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00060-17","journal-title":"Clin Microbiol Rev"},{"key":"2474_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4161\/bbug.1.6.13642","volume":"1","author":"J Carroll","year":"2010","unstructured":"Carroll J et al (2010) Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs. Bioeng Bugs 1:408\u2013412","journal-title":"Bioeng Bugs"},{"key":"2474_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/resp.13346","volume":"23","author":"CBE Chee","year":"2018","unstructured":"Chee CBE, Reves R, Zhang Y, Belknap R (2018) Latent tuberculosis infection: opportunities and challenges. Respirology 23:893\u2013900. https:\/\/doi.org\/10.1111\/resp.13346","journal-title":"Respirology"},{"key":"2474_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.peptides.2015.07.021","volume":"71","author":"S Chingate","year":"2015","unstructured":"Chingate S, Delgado G, Salazar LM, Soto CY (2015) The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP. Peptides 71:222\u2013228. https:\/\/doi.org\/10.1016\/j.peptides.2015.07.021","journal-title":"Peptides"},{"key":"2474_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.02.007","volume":"89","author":"L Corrales-Garcia","year":"2013","unstructured":"Corrales-Garcia L, Ortiz E, Castaneda-Delgado J, Rivas-Santiago B, Corzo G (2013) Bacterial expression and antibiotic activities of recombinant variants of human beta-defensins on pathogenic bacteria and M. tuberculosis. Protein Expr Purif 89:33\u201343. https:\/\/doi.org\/10.1016\/j.pep.2013.02.007","journal-title":"Protein Expr Purif"},{"key":"2474_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0966-842X(99)01696-0","volume":"8","author":"LE DesJardin","year":"2000","unstructured":"DesJardin LE, Schlesinger LS (2000) Identifying Mycobacterium tuberculosis virulence determinants\u2014new technologies for a difficult problem. Trends Microbiol 8:97\u2013100","journal-title":"Trends Microbiol"},{"key":"2474_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.peptides.2004.04.003","volume":"25","author":"L Fattorini","year":"2004","unstructured":"Fattorini L et al (2004) In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25:1075\u20131077. https:\/\/doi.org\/10.1016\/j.peptides.2004.04.003","journal-title":"Peptides"},{"key":"2474_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122219","author":"S Ferlita","year":"2019","unstructured":"Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K, Venketaraman V (2019) Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens especially Mycobacterium tuberculosis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8122219","journal-title":"J Clin Med"},{"key":"2474_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish E et al (2014) Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem Biol 21:509\u2013518. https:\/\/doi.org\/10.1016\/j.chembiol.2014.01.014","journal-title":"Chem Biol"},{"key":"2474_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/np9606456","volume":"60","author":"J Gerard","year":"1997","unstructured":"Gerard J, Lloyd R, Barsby T, Haden P, Kelly MT, Andersen RJ (1997) Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats. J Nat Prod 60:223\u2013229. https:\/\/doi.org\/10.1021\/np9606456","journal-title":"J Nat Prod"},{"key":"2474_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0031-2016","author":"B Gold","year":"2017","unstructured":"Gold B, Nathan C (2017) Targeting phenotypically tolerant Mycobacterium tuberculosis. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0031-2016","journal-title":"Microbiol Spectr"},{"key":"2474_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1021\/np900520b","volume":"73","author":"R Haritakun","year":"2010","unstructured":"Haritakun R, Sappan M, Suvannakad R, Tasanathai K, Isaka M (2010) An antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps communis BCC 16475. J Nat Prod 73:75\u201378. https:\/\/doi.org\/10.1021\/np900520b","journal-title":"J Nat Prod"},{"key":"2474_CR21","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1529\/biophysj.107.125542","volume":"94","author":"CW Harland","year":"2008","unstructured":"Harland CW, Rabuka D, Bertozzi CR, Parthasarathy R (2008) The Mycobacterium tuberculosis virulence factor trehalose dimycolate imparts desiccation resistance to model mycobacterial membranes. Biophys J 94:4718\u20134724","journal-title":"Biophys J"},{"key":"2474_CR22","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1080\/21645515.2016.1205769","volume":"12","author":"RC Harris","year":"2016","unstructured":"Harris RC, Sumner T, Knight GM, White RG (2016) Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines. Hum Vaccin Immunother 12:2813\u20132832. https:\/\/doi.org\/10.1080\/21645515.2016.1205769","journal-title":"Hum Vaccin Immunother"},{"key":"2474_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14787210.2018.1513324","volume":"16","author":"LA Hatzenbuehler","year":"2018","unstructured":"Hatzenbuehler LA, Starke JR (2018) Treatment of tuberculosis infection in children. Expert Rev Anti-Infect Ther 16:695\u2013708. https:\/\/doi.org\/10.1080\/14787210.2018.1513324","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2474_CR24","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s10989-018-9793-7","volume":"25","author":"S Horam","year":"2019","unstructured":"Horam S et al (2019) Xenobiotic binding domain of glutathione S-transferase has cryptic antimicrobial peptides. Int J Pept Res Ther 25:1477\u20131489. https:\/\/doi.org\/10.1007\/s10989-018-9793-7","journal-title":"Int J Pept Res Ther"},{"key":"2474_CR25","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/anie.200503381","volume":"45","author":"X Huang","year":"2006","unstructured":"Huang X, Roemer E, Sattler I, Moellmann U, Christner A, Grabley S (2006) Lydiamycins A-D: cyclodepsipetides with antimycobacterial properties. Angew Chem 45:3067\u20133072. https:\/\/doi.org\/10.1002\/anie.200503381","journal-title":"Angew Chem"},{"key":"2474_CR26","doi-asserted-by":"publisher","first-page":"e50345","DOI":"10.1371\/journal.pone.0050345","volume":"7","author":"P Jena","year":"2012","unstructured":"Jena P et al (2012) Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages. PLoS ONE 7:e50345. https:\/\/doi.org\/10.1371\/journal.pone.0050345","journal-title":"PLoS ONE"},{"key":"2474_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/092986611794578288","volume":"18","author":"Z Jiang","year":"2011","unstructured":"Jiang Z, Higgins MP, Whitehurst J, Kisich KO, Voskuil MI, Hodges RS (2011) Anti-tuberculosis activity of alpha-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Protein Pept Lett 18:241\u2013252. https:\/\/doi.org\/10.2174\/092986611794578288","journal-title":"Protein Pept Lett"},{"key":"2474_CR28","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1128\/AAC.01667-10","volume":"55","author":"R Kapoor","year":"2011","unstructured":"Kapoor R, Eimerman PR, Hardy JW, Cirillo JD, Contag CH, Barron AE (2011) Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis. Antimicrob Agents Chemother 55:3058\u20133062. https:\/\/doi.org\/10.1128\/AAC.01667-10","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR29","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1128\/IAI.69.4.2692-2699.2001","volume":"69","author":"KO Kisich","year":"2001","unstructured":"Kisich KO, Heifets L, Higgins M, Diamond G (2001) Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun 69:2692\u20132699","journal-title":"Infect Immun"},{"key":"2474_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/resp.13304","volume":"23","author":"C Lange","year":"2018","unstructured":"Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K (2018) Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology 23:656\u2013673. https:\/\/doi.org\/10.1111\/resp.13304","journal-title":"Respirology"},{"key":"2474_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/cid\/ciw836","volume":"64","author":"MR Lee","year":"2017","unstructured":"Lee MR et al (2017) Diabetes mellitus and latent tuberculosis infection: a systematic review and metaanalysis. Clin Infect Dis 64:719\u2013727. https:\/\/doi.org\/10.1093\/cid\/ciw836","journal-title":"Clin Infect Dis"},{"key":"2474_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jac\/47.5.575","volume":"47","author":"CM Linde","year":"2001","unstructured":"Linde CM, Hoffner SE, Refai E, Andersson M (2001) In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 47:575\u2013580. https:\/\/doi.org\/10.1093\/jac\/47.5.575","journal-title":"J Antimicrob Chemother"},{"key":"2474_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/sji.12567","volume":"86","author":"P Mendez-Samperio","year":"2017","unstructured":"Mendez-Samperio P (2017) Diagnosis of tuberculosis in HIV co-infected individuals: current status, challenges and opportunities for the future. Scand J Immunol 86:76\u201382. https:\/\/doi.org\/10.1111\/sji.12567","journal-title":"Scand J Immunol"},{"key":"2474_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","volume":"64","author":"Y Miyakawa","year":"1996","unstructured":"Miyakawa Y, Ratnakar P, Rao AG, Costello ML, Mathieu-Costello O, Lehrer RI, Catanzaro A (1996) In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 64:926\u2013932","journal-title":"Infect Immun"},{"key":"2474_CR35","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1128\/AAC.02475-12","volume":"57","author":"S Mohanty","year":"2013","unstructured":"Mohanty S, Jena P, Mehta R, Pati R, Banerjee B, Patil S, Sonawane A (2013) Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages. Antimicrob Agents Chemother 57:3688\u20133698. https:\/\/doi.org\/10.1128\/AAC.02475-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR36","unstructured":"Organization WH (2019) Global Tuberculosis Report 2019. Geneva, Switzerland: WHO; http:\/\/www.who.int\/tb\/publications\/. Accessed Dec 2017"},{"key":"2474_CR37","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/aac.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F (2002) Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2720\u20132722. https:\/\/doi.org\/10.1128\/aac.46.8.2720-2722.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/07388551.2011.594423","volume":"32","author":"M Pasupuleti","year":"2012","unstructured":"Pasupuleti M, Schmidtchen A, Malmsten M (2012) Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol 32:143\u2013171. https:\/\/doi.org\/10.3109\/07388551.2011.594423","journal-title":"Crit Rev Biotechnol"},{"key":"2474_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1099\/jmm.0.000912","volume":"68","author":"E Portell-Buj","year":"2019","unstructured":"Portell-Buj E et al (2019) In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates. J Med Microbiol 68:211\u2013215. https:\/\/doi.org\/10.1099\/jmm.0.000912","journal-title":"J Med Microbiol"},{"key":"2474_CR40","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1128\/AAC.00428-13","volume":"57","author":"D Pulido","year":"2013","unstructured":"Pulido D, Torrent M, Andreu D, Nogues MV, Boix E (2013) Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Antimicrob Agents Chemother 57:3797\u20133805. https:\/\/doi.org\/10.1128\/AAC.00428-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR41","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1128\/AAC.00175-13","volume":"57","author":"S Ramon-Garcia","year":"2013","unstructured":"Ramon-Garcia S et al (2013) Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. Antimicrob Agents Chemother 57:2295\u20132303. https:\/\/doi.org\/10.1128\/AAC.00175-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molimm.2016.09.015","volume":"78","author":"G Ravichandran","year":"2016","unstructured":"Ravichandran G et al (2016) Pellino-1 derived cationic antimicrobial prawn peptide: bactericidal activity, toxicity and mode of action. Mol Immunol 78:171\u2013182. https:\/\/doi.org\/10.1016\/j.molimm.2016.09.015","journal-title":"Mol Immunol"},{"key":"2474_CR43","doi-asserted-by":"publisher","first-page":"e59119","DOI":"10.1371\/journal.pone.0059119","volume":"8","author":"B Rivas-Santiago","year":"2013","unstructured":"Rivas-Santiago B et al (2013a) Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models. PLoS ONE 8:e59119. https:\/\/doi.org\/10.1371\/journal.pone.0059119","journal-title":"PLoS ONE"},{"key":"2474_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","volume":"41","author":"B Rivas-Santiago","year":"2013","unstructured":"Rivas-Santiago B, Rivas Santiago CE, Castaneda-Delgado JE, Leon-Contreras JC, Hancock RE, Hernandez-Pando R (2013b) Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Int J Antimicrob Agents 41:143\u2013148","journal-title":"Int J Antimicrob Agents"},{"key":"2474_CR45","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2174\/1381612824666180327162357","volume":"24","author":"B Rivas-Santiago","year":"2018","unstructured":"Rivas-Santiago B, Torres-Juarez F (2018) Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes? Curr Pharm Des 24:1138\u20131147. https:\/\/doi.org\/10.2174\/1381612824666180327162357","journal-title":"Curr Pharm Des"},{"key":"2474_CR46","doi-asserted-by":"publisher","first-page":"e101742","DOI":"10.1371\/journal.pone.0101742","volume":"9","author":"A Rodriguez","year":"2014","unstructured":"Rodriguez A, Villegas E, Montoya-Rosales A, Rivas-Santiago B, Corzo G (2014) Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis. PLoS ONE 9:e101742. https:\/\/doi.org\/10.1371\/journal.pone.0101742","journal-title":"PLoS ONE"},{"key":"2474_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.peptides.2012.04.018","volume":"36","author":"P Santos","year":"2012","unstructured":"Santos P, Gordillo A, Osses L, Salazar LM, Soto CY (2012) Effect of antimicrobial peptides on ATPase activity and proton pumping in plasma membrane vesicles obtained from mycobacteria. Peptides 36:121\u2013128. https:\/\/doi.org\/10.1016\/j.peptides.2012.04.018","journal-title":"Peptides"},{"key":"2474_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cis.2013.06.009","volume":"205","author":"A Schmidtchen","year":"2014","unstructured":"Schmidtchen A, Pasupuleti M, Malmsten M (2014) Effect of hydrophobic modifications in antimicrobial peptides. Adv Coll Interface Sci 205:265\u2013274. https:\/\/doi.org\/10.1016\/j.cis.2013.06.009","journal-title":"Adv Coll Interface Sci"},{"key":"2474_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0042-2017","author":"BJ Seaworth","year":"2017","unstructured":"Seaworth BJ, Griffith DE (2017) Therapy of multidrug-resistant and extensively drug-resistant tuberculosis. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0042-2017","journal-title":"Microbiol Spectr"},{"key":"2474_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10989-016-9553-5","volume":"23","author":"SC Setty","year":"2017","unstructured":"Setty SC, Horam S, Pasupuleti M, Haq W (2017) Modulating the antimicrobial activity of temporin L through introduction of fluorinated phenylalanine. Int J Pept Res Ther 23:213\u2013225. https:\/\/doi.org\/10.1007\/s10989-016-9553-5","journal-title":"Int J Pept Res Ther"},{"key":"2474_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","volume":"16","author":"S Sharma","year":"2000","unstructured":"Sharma S, Verma I, Khuller GK (2000) Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. Eur Respir J 16:112\u2013117. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.16a20.x","journal-title":"Eur Respir J"},{"key":"2474_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/AAC.45.2.639-640.2001","volume":"45","author":"S Sharma","year":"2001","unstructured":"Sharma S, Verma I, Khuller GK (2001) Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob Agents Chemother 45:639\u2013640","journal-title":"Antimicrob Agents Chemother"},{"key":"2474_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2016.05.064","volume":"235","author":"JP Silva","year":"2016","unstructured":"Silva JP et al (2016) Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment. J Control Release 235:112\u2013124. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.064","journal-title":"J Control Release"},{"key":"2474_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10096-016-2579-y","volume":"35","author":"VK Singh","year":"2016","unstructured":"Singh VK, Srivastava R, Srivastava BS (2016) Manipulation of BCG vaccine: a double-edged sword. Eur J Clin Microbiol Infect Dis 35:535\u2013543. https:\/\/doi.org\/10.1007\/s10096-016-2579-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2474_CR55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tube.2011.03.003","volume":"91","author":"FB Sow","year":"2011","unstructured":"Sow FB et al (2011) Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis 91:314\u2013321. https:\/\/doi.org\/10.1016\/j.tube.2011.03.003","journal-title":"Tuberculosis"},{"key":"2474_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/COH.0000000000000495","volume":"13","author":"JA Tornheim","year":"2018","unstructured":"Tornheim JA, Dooley KE (2018) Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS 13:486\u2013491. https:\/\/doi.org\/10.1097\/COH.0000000000000495","journal-title":"Curr Opin HIV AIDS"},{"key":"2474_CR57","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.micinf.2006.02.030","volume":"8","author":"JC Toro","year":"2006","unstructured":"Toro JC, Hoffner S, Linde C, Andersson M, Andersson J, Grundstrom S (2006) Enhanced susceptibility of multidrug resistant strains of mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype. Microbes Infect 8:1985\u20131993. https:\/\/doi.org\/10.1016\/j.micinf.2006.02.030","journal-title":"Microbes Infect"},{"key":"2474_CR58","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1021\/np020055+","volume":"65","author":"N Vongvanich","year":"2002","unstructured":"Vongvanich N, Kittakoop P, Isaka M, Trakulnaleamsai S, Vimuttipong S, Tanticharoen M, Thebtaranonth Y (2002) Hirsutellide A, a new antimycobacterial cyclohexadepsipeptide from the entomopathogenic fungus Hirsutella kobayasii. J Nat Prod 65:1346\u20131348","journal-title":"J Nat Prod"},{"key":"2474_CR59","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1002\/psc.3213","volume":"25","author":"S Yathursan","year":"2019","unstructured":"Yathursan S, Wiles S, Read H, Sarojini V (2019) A review on anti-tuberculosis peptides: impact of peptide structure on anti-tuberculosis activity. J Pept Sci 25:e3213. https:\/\/doi.org\/10.1002\/psc.3213","journal-title":"J Pept Sci"},{"key":"2474_CR60","first-page":"369","volume":"15","author":"LM Zhu","year":"2011","unstructured":"Zhu LM et al (2011) Multidrug-resistant tuberculosis is associated with low plasma concentrations of human neutrophil peptides 1\u20133. Int J Tuberc Lung Dis 15:369\u2013374","journal-title":"Int J Tuberc Lung Dis"},{"key":"2474_CR61","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1007\/s00253-019-09771-6","volume":"103","author":"S Zhu","year":"2019","unstructured":"Zhu S, Su Y, Shams S, Feng Y, Tong Y, Zheng G (2019) Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production. Appl Microbiol Biotechnol 103:3931\u20133940. https:\/\/doi.org\/10.1007\/s00253-019-09771-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"2474_CR62","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/14760584.2018.1483727","volume":"17","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Curtis N (2018) The influence of BCG on vaccine responses\u2014a systematic review. Expert Rev Vaccin 17:547\u2013554. https:\/\/doi.org\/10.1080\/14760584.2018.1483727","journal-title":"Expert Rev Vaccin"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-021-02474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-021-02474-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-021-02474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T16:03:22Z","timestamp":1633881802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-021-02474-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1007\/s00203-021-02474-5","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors saw the final version of the manuscript and approved it for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}